Apr 27, 2020
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Apr 21, 2020
Hillrom Introduces Five New Innovations To Help Caregivers Fight COVID-19
Apr 15, 2020
Roivant Doses First Patient in Pivotal BREATHE Clinical Trial Evaluating Gimsilumab in COVID-19 Patients for the Prevention and Treatment of Acute Respiratory Distress Syndrome
Apr 15, 2020
New Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and Acute Respiratory Distress Syndrome (ARDS) on ECMO
Apr 14, 2020
COVID-19 ARDS Patients Added to Healios ONE-BRIDGE Study
Apr 13, 2020
Vent Multiplexor Successfully Deployed at Yale New Haven Hospital for Crisis Care Co-Ventilation During COVID-19 Pandemic
Apr 10, 2020
Enzychem Lifesciences Announces Filing of U.S. Provisional Patent for EC-18 for the Treatment of COVID-19
Apr 09, 2020
Celularity Expands Strategic Collaboration with United Therapeutics Corporation to COVID-19 Infection and Acute Respiratory Distress Syndrome
Apr 08, 2020
Lamellar Biomedical Launches Program Designed to Prevent the Severe Respiratory Effects of COVID-19, Using its Unique LAMELLASOME(TM) Technology
Apr 06, 2020
Pulmonary Fibrosis Foundation Statement on COVID-19
Apr 02, 2020
Vanda Pharmaceuticals Announces the Initiation of ODYSSEY, an FDA Approved Clinical Study of Tradipitant in Hospitalized Patients with Severe COVID-19 Pneumonia
Apr 02, 2020
Ampio Pharmaceutical's Application to the FDA for a Clinical Study of Ampion(TM) to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)
Apr 01, 2020
Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection and Associated Lung Complications
Apr 01, 2020
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Apr 01, 2020
American Association Of Critical-Care Nurses Creates Custom COVID-19 Online Course
Apr 01, 2020
VIDA Diagnostics Commended by Frost & Sullivan for Transforming Respiratory Disease Care Globally with its LungPrint Suite
Apr 01, 2020
Vaccine for COVID-19 Health Crises "Possible" by Summer After FDA Fast-Tracks Clinical Trials
Apr 01, 2020
FibroGenesis Files Expanded Patent Coverage for its Fibroblast Cell Therapy to treat Coronavirus (COVID-19) ARDS
Mar 26, 2020
RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
Mar 26, 2020
Regarding HLCM051 for Acute Respiratory Distress Syndrome (ARDS) Caused by COVID -19